In:
International Journal of Cancer, Wiley, Vol. 145, No. 4 ( 2019-08-15), p. 1148-1161
Abstract:
What's new? Detection of recurrence in patients with myxoid liposarcomas is difficult and costly, as metastatic disease occurs throughout the body. Circulating DNA analysis holds the potential to improve and simplify cancer detection and treatment prediction, but to date it has mostly been adapted to carcinomas. Here, the authors demonstrate that quantification of circulating tumor‐DNA is also a feasible approach for monitoring tumor activity in patients with myxoid liposarcomas. The novel approach would enable timely, non‐invasive detection of minimal residual disease and tumor recurrence and therefore improve treatment.
Type of Medium:
Online Resource
ISSN:
0020-7136
,
1097-0215
Language:
English
Publisher:
Wiley
Publication Date:
2019
detail.hit.zdb_id:
218257-9
detail.hit.zdb_id:
1474822-8
Bookmarklink